Fred A Middleton bought $404k of CALC
director, owner at CalciMedica, Inc.. 107,744 shares at an average of $3.75, traded Nov 1, 2024, filed Nov 5, 2024.
Score components
- +15RoleDirector
- +16Trade size$404k at market
- +10Relative to holdingsHoldings up 920%
- 0Price contextNo price history yet
- +15Cluster5 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.5%, 3m -27.7%, 6m -43.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-026102, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | POpen-market purchase Common Stock | +20,000 | $3.75 | $75k | 31,714 | Nov 5, 2024 |
| Nov 1, 2024 | POpen-market purchase Common Stockindirect: By Sanderling Venture Partners VI Co-Investment Fund, L.P. | +86,867 | $3.75 | $326k | 814,300 | Nov 5, 2024 |
| Nov 1, 2024 | POpen-market purchase Common Stockindirect: By Sanderling Ventures Management VI | +877 | $3.75 | $3,289 | 22,479 | Nov 5, 2024 |
Related signals
Other insiders at CalciMedica, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $7,675 2,500 shares | +3% | |
| 28Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $9,105 3,400 shares | +4% | |
| 31Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $16k 5,000 shares | +7% | |
| 24Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $7,378 2,343 shares | +3% | |
| 44Moderate | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $29k 10,000 shares | +16% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $9,797 3,508 shares | +6% | |
| 44Moderate | CalciMedica, Inc. | Sudarshan Hebbar Chief Medical Officer | $27k 9,563 shares | +18% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $8,230 3,000 shares | +6% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $15k 5,076 shares | +10% | |
| 34Weak | CalciMedica, Inc. | Sudarshan Hebbar Chief Medical Officer | $16k 5,976 shares | +13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.